The number of NGS platforms, differences in their performance metrics and the applications they can be used for, ranging from whole genome sequencing to targeted gene sequencing, can make evaluation difficult. In addition, this is a dynamic field meaning that any framework will have to be flexible to changes in the technologies and their applications. As sequencing is already beginning to be used in the clinical setting, considering these issues is an important aspect of ensuring their safe implementation. The PHG Foundation is undertaking a project looking at the impact of new DNA sequencing technologies for health.

comments powered by Disqus